Zylox-Tonbridge to Acquire Optimed Medizinische Instrumente GmbH

January 16, 2026

Zylox-Tonbridge entered into a definitive agreement to acquire Germany-based medical device company Optimed Medizinische Instrumente GmbH in multiple steps, with an option to acquire its entire equity interest from existing shareholders. The deal is intended to create an integrated global commercialization platform for Optimed’s minimally invasive vascular and endourology products and to deliver manufacturing and operational synergies between Germany and China.

Buyers
Zylox-Tonbridge
Targets
Optimed Medizinische Instrumente GmbH
Sellers
Existing shareholders of Optimed Medizinische Instrumente GmbH
Industry
Medical Devices
Location
Germany
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.